Apart from small cell and neuroendocrine lineages, the frequent presence of RB1/TP53 co-mutation in sarcomas suggests RB1/TP53 co-mutation may not be sufficient to sustain cells in the neuroendocrine lineage. The gene discussed is RB1; the disease is sarcoma.